| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | -5.4% |
| Cost of Revenue | $3.1M | +2.7% |
| Gross Profit | $5.1M | -9.7% |
| R&D Expense | $2.7M | -15.5% |
| SG&A Expense | $13.5M | +0.5% |
| Operating Income | -$11.1M | -1.1% |
| Pre-tax Income | -$17.5M | -57.0% |
| Income Tax | $5K | +0.0% |
| Net Income | -$17.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -78.7% |
| Accounts Receivable | $1.5M | -13.5% |
| Inventory | $1.9M | +11.2% |
| Current Assets | $5.2M | -41.4% |
| Total Assets | $6.1M | -38.0% |
| Current Liabilities | $3.0M | +18.5% |
| Total Liabilities | $3.5M | +4.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.8M | -12.7% |
| Capital Expenditures | $90K | +50.0% |
| Investing Cash Flow | -$90K | -50.0% |
| Financing Cash Flow | $6.9M | -36.7% |
| Free Cash Flow | -$10.9M | -12.9% |
| -56.9% |
| EPS (Basic) | -$25.39 | -201.9% |
| EPS (Diluted) | -$25.39 | -201.9% |
| Stockholders' Equity |
| $2.6M |
| -59.8% |